BPI Analytical and Quality Summit 
Event Information
Document Title
Speakers
- Wasfi Al-Azzam, Ph.D., Talecris Biotherapeutics
- Tudor Arvinte, Ph.D., University of Geneva, Switzerland
- Hanne Bak, Ph.D., Regeneron Pharmaceuticals
- Jamie Bailey, Genzyme Corporation
- Mark Bailey, SAS Institute, Inc.
- Svetlana Bergelson, Ph.D., Biogen Idec, Inc.
- Steven A. Berkowitz, Ph.D., Biogen Idec, Inc.
- Angela W. Blake-Haskins, Ph.D., Human Genome Sciences, Inc.
- Katherine E. Bowers, Ph.D., Diosynth Biotechnology
- Scott Burian, Ph.D., Cato Research
- Gail Burnett, Ph.D., Genentech, Inc.
- Christine P. Chan, Ph.D., Merck & Co., Inc.
- Suhe Chen, Ph.D., Human Genome Sciences, Inc.
- K.C. Cheng, Ph.D., MBA, Medarex, Inc.
- John H Chon, Ph.D., Percivia
- Judy Chou, Ph.D., Genentech, Inc.
- David J. Cirelli, Wyeth BioPharma
- Diana M. Colleluori, Ph.D., AppTec, Inc.
- Sarah Demmon, Eli Lilly and Company
- Stefan Fischer, Ph.D., F. Hoffmann-La Roche Ltd., Switzerland
- Ian Fitzpatrick M.Eng.Sci, Invetech, Pty.
- Ewa Folta-Stogniew, Ph.D., Yale University School of Medicine
- Sathish Hasige Ph.D., MedImmune, Inc.
- Sonoko Kanai, Ph.D., Genentech, Inc.
- Martin Kane, MS, CRE, Human Genome Sciences, Inc.
- Bo Kara, Avecia Biologics Ltd., United Kingdom
- Chulani Karunatilake, Ph.D., Amgen, Inc.
- Robert Kitchen, Wyeth BioPharma
- Janus Krarup, MSc, Novo Nordisk A/S, Denmark
- Stephan Krause, Ph.D., Favrille, Inc.
- Rajesh Krishnamurthy, Ph.D., ImmunoGen, Inc.
- Sigrid C. Kuebler, Ph.D., Wyatt Technology Corporation
- Sandeep Kumar, Ph.D., Pfizer Global Biologics
- David Lansky, Ph.D., Precision Bioassay
- Brian Lentrichia, Ph.D., Shire Human Genetic Therapies
- Dingjiang Liu, Ph.D., Amgen, Inc.
- Jun Liu, Ph.D., Genentech, Inc.
- Yin Luo, Ph.D., Wyeth BioPharma
- Sheila G. Magil, Ph.D., BioProcess Technology Consultants, Inc.
- George Makhatadze, Ph.D., Rensselaer Polytechnic Institute
- Rohin Mhatre, Ph.D., Biogen Idec, Inc.
- Guillermo Miroquesada, Ph.D., Eli Lilly and Company
- Mark D. Moody, Ph.D., Merrimack Pharmaceuticals
- Bilikallahalli Muralidhara, Ph.D., Pfizer Global Biologics
- Leonard F. Pease III, Ph.D., National Institute of Standards and Technology
- Itzcoatl A. Pla, Ph.D., Abbott Bioresearch Center
- Thomas J. Porter, Ph.D., Wyeth Biopharma
- Stephen Raso, Ph.D., Wyeth BioPharma
- Da Ren, Ph.D., Amgen, Inc.
- Nadine M. Ritter, Ph.D., Biologics Consulting Group, Inc.
- Dieter Schmalzing, Ph.D., Genentech, Inc.
- Anindita Sen, Ph.D., Eli Lilly and Company
- Rob Simler, Ph.D., Genzyme Corporation
- Andy Stadheim, Ph.D., GlycoFi, Inc.
- W. Blaine Stine Ph.D., Abbott Bioresearch Center
- Mike Su, Ph.D., Bayer Corporate and Business Services LLC
- Max Tejada. Ph.D., Genentech, Inc.
- Alex Tracy, Ph.D., KBI Biopharma
- Robert Troutman, Merck & Co.
- Cenk Undey, Ph.D., Amgen, Inc.
- Jeroen Lammerts van Bueren, Ph.D., Genmab B.V., The Netherlands
- Abdul Wajid, Ph.D., XOMA (US) LLC
- Yong Wang, Ph.D., ImmunoGen, Inc.
- Bobbie-Jo Webb-Robertson, Ph.D., Pacific Northwest National Laboratory
- Marc Wenger, Merck & Co., Inc.
- Adrienne L. Williams, West Pharmaceutical Services
- Margaret Worden, Stryker Biotech
- Seongkyu Yoon, Ph.D., Biogen Idec, Inc.
Bottom menu
Copyright IBC Life Sciences, a part of Informa Life Sciences Group